Skip to content

Validation of PRECISE-DAPT score for prediction of bleeding complication after coronary stent implantation in Thai population

Validation of PRECISE-DAPT score for prediction of bleeding complication after coronary stent implantation in Thai population

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20210802004
Enrollment
960
Registered
2021-08-02
Start date
2018-06-13
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients who were underwent coronary stent implantation with DAPT PRECISE-DAPT score, Bleeding, Dual antiplatelet therapy, coronary stent implantation.

Interventions

Patients who underwent coronary stent implantation and received DAPT in Siriraj Hospital during June 2018 through December 2019.
Device Feasibility
Patients who underwent coronary stent implantation and received DAPT.

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with over 18 years old who were underwent coronary stent implantation and received DAPT (81-325 mg aspirin plus 75 mg/day clopidogrel, 10 mg/day prasugrel or 180 mg/day ticagrelor).

Exclusion criteria

Exclusion criteria: Patients receiving oral anticoagulant therapy, pregnancy and surgical planning within 12 months after coronary stent implantation.

Design outcomes

Primary

MeasureTime frame
One-year out-of-hospital bleeding One-year An estimate of the hazard ratio of bleeding between two groups.

Secondary

MeasureTime frame
One-year major adverse cardiovascular events (MACE) One-year An estimate of the hazard ratio of MACE between two groups.

Countries

Thailand

Contacts

Public ContactNattawut Wongpraparut

Faculty of Medicine Siriraj Hospital

wongpraparut@yahoo.com0897954422

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026